论文部分内容阅读
目的评价丙酸倍氯米松鼻喷雾剂(伯克纳)治疗变应性鼻炎的临床疗效;方法以呋麻液加地塞米松为对照用药,采用开放性、随机对照临床试验的方法治疗变应性鼻炎。结果伯克纳组有效率为93.3%,呋麻液组有效率为31.7%。结论丙酸倍氯米松鼻喷雾剂可以迅速缓解症状,控制炎症,是治疗变应性鼻炎的安全、有效药物。
Objective To evaluate the clinical efficacy of beclomethasone dipropionate nasal spray (Berkana) in the treatment of allergic rhinitis. Methods: A controlled, open-label and randomized clinical trial was conducted with furosemide plus dexamethasone rhinitis. Results The effective rate was 93.3% in the Burkina group and 31.7% in the furosemide group. Conclusion beclometasone dipropionate nasal spray can quickly relieve symptoms and control inflammation and is a safe and effective drug for the treatment of allergic rhinitis.